{
"info": {
"nct_id": "NCT02830282",
"official_title": "Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer",
"inclusion_criteria": "* Enrollment on the treatment phase of the I-SPY 2 TRIAL\n* Completed a standard neoadjuvant chemotherapy regimen or assigned treatment on I-SPY 2 and planning definitive surgical resection. Participants who have discontinued assigned treatment on I-SPY 2, switched to standard of care, and have completed a standard neoadjuvant chemotherapy regimen are still considered eligible.\n* Pre-surgical imaging or clinical examination demonstrating residual disease in the breast. Participants with any extent of enhancement attributable to tumor on the pre-surgical MRI are eligible. No minimum extent of palpable tumor pre-surgery is required.\n* Willing to undergo bone marrow aspiration and blood specimen collection per protocol specifications\n* No clinical evidence of distant metastatic disease. Pre-chemotherapy staging scans are sufficient in the absence of any symptoms or subsequent clinical evidence suggesting distant metastases\n* Age 18 or over and are able to give informed consent\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Individuals under the age of 18\n* Individuals who cannot understand and give informed consent. We will not be assessing decisional capacity; determination of ability to give informed consent will be at the discretion of the treating physician.\n* Pregnancy. Participants in the parent I-SPY 2 TRIAL are screened for pregnancy at enrollment and pregnancy is an exclusion criteria. No additional screening for pregnancy is required for participants enrolling on SURMOUNT. However if a study participant does become pregnant while on study or during the course of the 10 year follow-up, the study participant will remain on the study protocol and will not be withdrawn. Because this is an observational study and does not have a therapeutic component, there will be no increased risk to following a study participant through annual blood draws and medical information abstraction from the medical chart who may or may not become pregnant during the course of the follow-up period.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Enrollment on the treatment phase of the I-SPY 2 TRIAL",
"criterions": [
{
"exact_snippets": "Enrollment on the treatment phase of the I-SPY 2 TRIAL",
"criterion": "enrollment on treatment phase",
"requirement": {
"requirement_type": "trial",
"expected_value": "I-SPY 2 TRIAL"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Enrollment on the treatment phase of the I-SPY 2 TRIAL",
"criterion": "enrollment on treatment phase",
"requirement": {
"requirement_type": "trial",
"expected_value": "I-SPY 2 TRIAL"
}
}
]
}
},
{
"identified_line": {
"line": "* Completed a standard neoadjuvant chemotherapy regimen or assigned treatment on I-SPY 2 and planning definitive surgical resection. Participants who have discontinued assigned treatment on I-SPY 2, switched to standard of care, and have completed a standard neoadjuvant chemotherapy regimen are still considered eligible.",
"criterions": [
{
"exact_snippets": "Completed a standard neoadjuvant chemotherapy regimen",
"criterion": "neoadjuvant chemotherapy regimen",
"requirement": {
"requirement_type": "completion",
"expected_value": true
}
},
{
"exact_snippets": "assigned treatment on I-SPY 2",
"criterion": "I-SPY 2 treatment",
"requirement": {
"requirement_type": "assignment",
"expected_value": true
}
},
{
"exact_snippets": "planning definitive surgical resection",
"criterion": "definitive surgical resection",
"requirement": {
"requirement_type": "planning",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Completed a standard neoadjuvant chemotherapy regimen",
"criterion": "neoadjuvant chemotherapy regimen",
"requirement": {
"requirement_type": "completion",
"expected_value": true
}
},
{
"exact_snippets": "assigned treatment on I-SPY 2",
"criterion": "I-SPY 2 treatment",
"requirement": {
"requirement_type": "assignment",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Completed a standard neoadjuvant chemotherapy regimen",
"criterion": "neoadjuvant chemotherapy regimen",
"requirement": {
"requirement_type": "completion",
"expected_value": true
}
},
{
"exact_snippets": "assigned treatment on I-SPY 2",
"criterion": "I-SPY 2 treatment",
"requirement": {
"requirement_type": "assignment",
"expected_value": false
}
}
]
}
]
},
{
"exact_snippets": "planning definitive surgical resection",
"criterion": "definitive surgical resection",
"requirement": {
"requirement_type": "planning",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Pre-surgical imaging or clinical examination demonstrating residual disease in the breast. Participants with any extent of enhancement attributable to tumor on the pre-surgical MRI are eligible. No minimum extent of palpable tumor pre-surgery is required.",
"criterions": [
{
"exact_snippets": "Pre-surgical imaging or clinical examination demonstrating residual disease in the breast.",
"criterion": "residual disease in the breast",
"requirement": {
"requirement_type": "demonstration",
"expected_value": true
}
},
{
"exact_snippets": "Participants with any extent of enhancement attributable to tumor on the pre-surgical MRI are eligible.",
"criterion": "enhancement attributable to tumor on the pre-surgical MRI",
"requirement": {
"requirement_type": "extent",
"expected_value": "any"
}
},
{
"exact_snippets": "No minimum extent of palpable tumor pre-surgery is required.",
"criterion": "palpable tumor pre-surgery",
"requirement": {
"requirement_type": "minimum extent",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Pre-surgical imaging or clinical examination demonstrating residual disease in the breast.",
"criterion": "residual disease in the breast",
"requirement": {
"requirement_type": "demonstration",
"expected_value": true
}
},
{
"exact_snippets": "Participants with any extent of enhancement attributable to tumor on the pre-surgical MRI are eligible.",
"criterion": "enhancement attributable to tumor on the pre-surgical MRI",
"requirement": {
"requirement_type": "extent",
"expected_value": "any"
}
}
]
},
{
"exact_snippets": "No minimum extent of palpable tumor pre-surgery is required.",
"criterion": "palpable tumor pre-surgery",
"requirement": {
"requirement_type": "minimum extent",
"expected_value": false
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Willing to undergo bone marrow aspiration and blood specimen collection per protocol specifications",
"criterions": [
{
"exact_snippets": "Willing to undergo bone marrow aspiration",
"criterion": "bone marrow aspiration",
"requirement": {
"requirement_type": "willingness",
"expected_value": true
}
},
{
"exact_snippets": "Willing to undergo ... blood specimen collection",
"criterion": "blood specimen collection",
"requirement": {
"requirement_type": "willingness",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Willing to undergo bone marrow aspiration",
"criterion": "bone marrow aspiration",
"requirement": {
"requirement_type": "willingness",
"expected_value": true
}
},
{
"exact_snippets": "Willing to undergo ... blood specimen collection",
"criterion": "blood specimen collection",
"requirement": {
"requirement_type": "willingness",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* No clinical evidence of distant metastatic disease. Pre-chemotherapy staging scans are sufficient in the absence of any symptoms or subsequent clinical evidence suggesting distant metastases",
"criterions": [
{
"exact_snippets": "No clinical evidence of distant metastatic disease",
"criterion": "distant metastatic disease",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "Pre-chemotherapy staging scans are sufficient in the absence of any symptoms or subsequent clinical evidence suggesting distant metastases",
"criterion": "symptoms or subsequent clinical evidence suggesting distant metastases",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
"then_criteria": {
"exact_snippets": "No clinical evidence of distant metastatic disease",
"criterion": "distant metastatic disease",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Age 18 or over and are able to give informed consent",
"criterions": [
{
"exact_snippets": "Age 18 or over",
"criterion": "age",
"requirement": {
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
},
{
"exact_snippets": "able to give informed consent",
"criterion": "ability to give informed consent",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Age 18 or over",
"criterion": "age",
"requirement": {
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
},
{
"exact_snippets": "able to give informed consent",
"criterion": "ability to give informed consent",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirement": {
"requirement_type": "expected_value",
"expected_value": "female"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirement": {
"requirement_type": "expected_value",
"expected_value": "female"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Individuals under the age of 18",
"criterions": [
{
"exact_snippets": "under the age of 18",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<",
"value": 18,
"unit": "years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "under the age of 18",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<",
"value": 18,
"unit": "years"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Individuals who cannot understand and give informed consent. We will not be assessing decisional capacity; determination of ability to give informed consent will be at the discretion of the treating physician.",
"criterions": [
{
"exact_snippets": "cannot understand and give informed consent",
"criterion": "ability to give informed consent",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "cannot understand and give informed consent",
"criterion": "ability to give informed consent",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"identified_line": {
"line": "* Pregnancy. Participants in the parent I-SPY 2 TRIAL are screened for pregnancy at enrollment and pregnancy is an exclusion criteria. No additional screening for pregnancy is required for participants enrolling on SURMOUNT. However if a study participant does become pregnant while on study or during the course of the 10 year follow-up, the study participant will remain on the study protocol and will not be withdrawn. Because this is an observational study and does not have a therapeutic component, there will be no increased risk to following a study participant through annual blood draws and medical information abstraction from the medical chart who may or may not become pregnant during the course of the follow-up period.",
"criterions": [
{
"exact_snippets": "screened for pregnancy at enrollment",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "screening",
"expected_value": true
}
},
{
"exact_snippets": "pregnancy is an exclusion criteria",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "exclusion",
"expected_value": true
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
}
],
"failed_miscellaneous": []
}